StreetInsider.com News Articles

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 11 Filed by: WIRTJES SEAN M

Thu, 12 Mar 2026 19:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26155038.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 11 Filed by: WIRTJES SEAN M

Thu, 12 Mar 2026 19:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26155038.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 11 Filed by: Wilson John J. Addington

Thu, 12 Mar 2026 19:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26155040.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 11 Filed by: Wilson John J. Addington

Thu, 12 Mar 2026 19:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26155040.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 10 Filed by: Spignesi Robert G. Jr.

Thu, 12 Mar 2026 19:52:00 -0400

si-local-file:///var/storage/secattach/20260312/26155035.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Mar 10 Filed by: Spignesi Robert G. Jr.

Thu, 12 Mar 2026 19:52:00 -0400

si-local-file:///var/storage/secattach/20260312/26155035.html

Form S-8 RAPID MICRO BIOSYSTEMS,

Thu, 12 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260312/26154538.html

Form S-8 RAPID MICRO BIOSYSTEMS,

Thu, 12 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260312/26154538.html

Form 10-K RAPID MICRO BIOSYSTEMS, For: Dec 31

Thu, 12 Mar 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26154183.html

Form 10-K RAPID MICRO BIOSYSTEMS, For: Dec 31

Thu, 12 Mar 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260312/26154183.html

Form 8-K RAPID MICRO BIOSYSTEMS, For: Mar 12

Thu, 12 Mar 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260312/26149170.html

Form 8-K RAPID MICRO BIOSYSTEMS, For: Mar 12

Thu, 12 Mar 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260312/26149170.html

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Thu, 12 Mar 2026 07:00:00 -0400

Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024
Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024
Amgen expands global Growth Direct system rollout with significant multi-system order in the fourth quarter 2025; will sponsor North American Growth Direct Day in the second quarter 2026
Samsung Biologics continues to expand Growth Direct deployment across its manufacturing network with a meaningful multi-system order in the first quarter 2026
For the full year 2026, the Company expects total revenue in the range of

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Thu, 12 Mar 2026 07:00:00 -0400

Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024

Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024

Amgen expands global Growth Direct system rollout with significant multi-system order in the fourth quarter 2025; will sponsor North American Growth Direct Day in the second quarter 2026

Samsung Biologics continues to expand Growth Direct deployment across its manufacturing network with a meaningful multi-system order in the first quarter 2026

For the full year 2026, the Company expects total revenue in the range of

Samsung Biologics orders additional Growth Direct systems from Rapid Micro

Thu, 12 Mar 2026 06:30:43 -0400

Rapid Micro Biosystems Inc. (NASDAQ: RPID) announced Samsung Biologics has placed a follow-on multi-system order for its Growth Direct platform to expand automated microbiology quality control across Samsung's manufacturing network.
The order builds on an existing partnership between the companies. Samsung Biologics operates as a contract development and manufacturing organization.
"Samsung Biologics is a leading global contract development and manufacturing organization and we're pleased to strengthen our partnership with this new multi-system order," said Robert Spignesi, President and CEO of Rapid Micro Biosystems. "The Growth Direct platform enhances that foundation by delivering faster time to results, greater accuracy, and stronger data integrity."
The

Samsung Biologics orders additional Growth Direct systems from Rapid Micro

Thu, 12 Mar 2026 06:30:43 -0400

Rapid Micro Biosystems Inc. (NASDAQ: RPID) announced Samsung Biologics has placed a follow-on multi-system order for its Growth Direct platform to expand automated microbiology quality control across Samsung's manufacturing network.
The order builds on an existing partnership between the companies. Samsung Biologics operates as a contract development and manufacturing organization.
"Samsung Biologics is a leading global contract development and manufacturing organization and we're pleased to strengthen our partnership with this new multi-system order," said Robert Spignesi, President and CEO of Rapid Micro Biosystems. "The Growth Direct platform enhances that foundation by delivering faster time to results, greater accuracy, and stronger data integrity."
The

Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform

Thu, 12 Mar 2026 06:30:00 -0400

Companies deepen partnership to advance automated, integrated microbiology quality control
LEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced a new multi-system order from Samsung Biologics for its Growth Direct platform.

This follow-on order builds on the companies’ existing partnership and supports Samsung’s continued expansion of the Growth Direct platform to automate microbial quality control across its manufacturing network.

“Samsung Biologics is

Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform

Thu, 12 Mar 2026 06:30:00 -0400

Companies deepen partnership to advance automated, integrated microbiology quality control
LEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced a new multi-system order from Samsung Biologics for its Growth Direct platform.

This follow-on order builds on the companies’ existing partnership and supports Samsung’s continued expansion of the Growth Direct platform to automate microbial quality control across its manufacturing network.

“Samsung Biologics is

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: WIRTJES SEAN M

Wed, 11 Mar 2026 15:15:00 -0400
si-local-file:///var/storage/secattach/20260311/26145640.html

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: WIRTJES SEAN M

Wed, 11 Mar 2026 15:15:00 -0400
si-local-file:///var/storage/secattach/20260311/26145640.html

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: Wilson John J. Addington

Wed, 11 Mar 2026 15:11:00 -0400
si-local-file:///var/storage/secattach/20260311/26145631.html

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: Wilson John J. Addington

Wed, 11 Mar 2026 15:11:00 -0400
si-local-file:///var/storage/secattach/20260311/26145631.html

Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

Tue, 10 Mar 2026 16:45:00 -0400

LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the KeyBanc Capital Markets Healthcare Forum.

The Company is scheduled to participate in a virtual question and answer session with the host analyst on Tuesday, March 17, 2026, at 11:15 a.m. Eastern Time. A live webcast will be available on the Rapid Micro Biosystems investor relations website at

Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

Tue, 10 Mar 2026 16:45:00 -0400

LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the KeyBanc Capital Markets Healthcare Forum.

The Company is scheduled to participate in a virtual question and answer session with the host analyst on Tuesday, March 17, 2026, at 11:15 a.m. Eastern Time. A live webcast will be available on the Rapid Micro Biosystems investor relations website at

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: Spignesi Robert G. Jr.

Tue, 10 Mar 2026 16:27:00 -0400
si-local-file:///var/storage/secattach/20260310/26139844.html